Concepedia
Statistics
Publications
38
Citations
2.3K
H-Index
24
Active since
1987
Affiliations
Temple University(Current)
Icahn School of Medicine at Mount Sinai
Onconova Therapeutics (United States)
Kingsborough Community College
City University of New York
Stephen C. Cosenza is an author at Temple University specializing in medicine, pharmacology, and cell biology.
Top concepts
MedicinePharmacologyCell BiologyRadiation OncologyTumor BiologyDrug DiscoveryNatural SciencesCancer ResearchMedicinal ChemistryCell Cycle
Publications per year
1987–2021
ON01910, a non-ATP-competitive small molecule inhibitor of Plk1, is a potent anticancer agent
Kiranmai Gumireddy, M. V. Ramana Reddy, Stephen C. Cosenza et al. · Cancer Cell · 2005 · 366 citations · Full text
Medicine, Potent Anticancer Agent, Anti-cancer Agent +5
A Small Molecule RAS-Mimetic Disrupts RAS Association with Effector Proteins to Block Signaling
Sai Krishna Athaluri Divakar, Rodrigo Vasquez‐Del Carpio, Kaushik Dutta et al. · Cell · 2016 · 259 citations · Full text
Block Signaling, Signal Transduction, Effector Proteins +9
A non-ATP-competitive inhibitor of BCR-ABL overrides imatinib resistance
Kiranmai Gumireddy, Stacey J. Baker, Stephen C. Cosenza et al. · Proceedings of the National Academy of Sciences · 2005 · 221 citations · Full text
Germ Line Transmission of the <i>Cdk4</i><sup>R24C</sup> Mutation Facilitates Tumorigenesis and Escape from Cellular Senescence
Sushil G. Rane, Stephen C. Cosenza, Richard V. Mettus et al. · Molecular and Cellular Biology · 2002 · 167 citations · Full text
Synthesis of new coumarin 3-(N-aryl) sulfonamides and their anticancer activity
Natala Srinivasa Reddy, Muralidhar R. Mallireddigari, Stephen C. Cosenza et al. · Bioorganic & Medicinal Chemistry Letters · 2004 · 164 citations
Medicinal Chemistry, Derivative (Chemistry), Natural Sciences +8
Rows per page
1–5 of 38